Open AccessNeoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028714
Subject(s) - medicine , oncology , chemotherapy , p53 expression , invasive ductal carcinoma , ductal carcinoma , gynecology , cancer research , immunohistochemistry , cancer , breast cancer